Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.
Saved in:
| Title: | Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. |
|---|---|
| Authors: | Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Manley PW; Novartis Pharma AG, Basel, Switzerland; and., Larson RA; Department of Medicine, University of Chicago, Chicago, IL., Capdeville R; Novartis Pharma AG, Basel, Switzerland; and. |
| Source: | Blood advances [Blood Adv] 2018 Feb 27; Vol. 2 (4), pp. 444-453. |
| Publication Type: | Historical Article; Journal Article; Review |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2473-9537 |
|---|---|
| DOI: | 10.1182/bloodadvances.2017011080 |
